FDA's Color Books: Classification and Information on Medical Products

FDA’s Color Books: Classification and Information on Medical Products

The FDA uses various “color books” to classify and provide specific information regarding different categories of medical products. Each book focuses on a particular area, aiding professionals in identifying key information related to drugs, biological products, or medical devices.

1. Orange Book
Full Title: Approved Drug Products with Therapeutic Equivalence Evaluations
Purpose: Lists drug products approved by the FDA based on safety and effectiveness under the Federal Food, Drug, and Cosmetic Act.
Focus: Therapeutic equivalence of generic drugs and patent/exclusivity details.

2. Purple Book
Full Title: Lists of Licensed Biological Products with Reference Product Exclusivity and Biosimilarity or Interchangeability Evaluations
Purpose: Provides information on biological products, including biosimilars and interchangeable biological products.
Focus: Biosimilars and biologics approved under the Public Health Service Act.

3. Green Book
Full Title: FDA Approved Animal Drug Products
Purpose: Lists animal drug products approved by the FDA.
Focus: Drugs for veterinary use, including therapeutic equivalence for generic animal drugs.

4. Yellow Book
Full Title: Health Information for International Travel
Purpose: Published by the CDC (Centers for Disease Control and Prevention), not the FDA. It contains guidelines for health recommendations for international travel.
Focus: Vaccination and prevention measures for travelers.

5. Red Book
Full Title: Report of the Committee on Infectious Diseases
Purpose: Published by the American Academy of Pediatrics (AAP), not directly an FDA book. It provides guidelines for the diagnosis, treatment, and prevention of pediatric infectious diseases.
Focus: Pediatric infectious disease management and immunization schedules.

6. Blue Book
Full Title: Compliance Program Guidance Manual
Purpose: Provides guidance to FDA field personnel regarding regulatory actions and compliance policies.
Focus: Ensures the uniformity of inspections and regulatory enforcement actions related to drugs and devices.

These books are key reference tools for health professionals, pharmacists, and regulators, helping them navigate the regulatory environment surrounding drugs, biologics, animal products, and more.